For AI assistants & researchers — machine-readable summary of this page
What this page is: Delvantic's full research page for Mitsubishi UFJ Financial Group, Inc. (MUFG) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.
Our current read (analysis of 2026-08-11): Designation Gem · Cairn score +39 (−100…+100 Quality+Value blend) · Quality 41 · Value 37 · Sentiment 1 (timing only, not weighted) · Composite fair value $43.53 vs $22.45 at analysis
Page map (sections in order; each card carries a stable
reference-name attribute you can cite):
profile-header/price-overview— company profile, live quote, market capextended-analysis— the core: three AI lens reads with findings, scores, and the analyst memofuture-predictions— our forward price-band predictionsmarket-narrative/ai-findings/gpt-critique— narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)- Members-only sections (render as login gates for anonymous readers):
price-history,income-trend,key-metrics,financials(statement tables),insider-trading. The analysis above is public; the raw data tables require a free account.
More for machine readers: site briefing at
/llms.txt ·
any ticker resolves at delvantic.com/stock/TICKER ·
raw inputs are public-company filings and market data (via licensed data feeds);
every model, score, lens read, and prediction on this page is Delvantic's own analysis.
Mitsubishi UFJ Financial Group, Inc. Sponsored ADR represents an interest in Mitsubishi UFJ Financial Group, Inc., a Japanese bank holding and financial services company headquartered in Tokyo. The group provides a broad spectrum of financial services, including commercial and retail banking, corporate and investment banking, trust banking, securities brokerage, asset management, leasing, and consumer finance. It serves individuals, small and medium-sized enterprises, large corporations, financial institutions, and public-sector entities. The company operates through diversified business segments such as retail and commercial banking, corporate banking, global banking, trust assets, and credit card and consumer finance operations. Its offerings span deposits, lending, payment and settlement services, foreign exchange, trade finance, project and structured finance, as well as investment products like mutual funds and structured notes. Mitsubishi UFJ Financial Group, Inc. Sponsored ADR allows international investors to gain exposure to one of Japan’s largest and most globally connected financial groups, which plays a central role in capital intermediation, cross-border financing, and investment services across Asia, the Americas, and Europe.
Earnings Schedule
Checked daily · calendar updated Aug 11| Print date | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| Aug 3, 2026 | $0.34 | $0.45 +32.4% | — | — |
| May 15, 2026 | $0.20 | $0.34 +70.0% | — | — |
| Mar 24, 2026 | $-0.40 | $-1.00 -150.0% | — | — |
| Feb 4, 2026 | $0.30 | $0.29 -3.3% | — | — |
| Jan 7, 2026 | $1.94 | $2.13 +9.8% | — | — |
Green = beat the estimate, red = missed. An earnings print is the fastest way a thesis changes — our designations should be re-read after each one.
Recent SEC Filings
Last updated: Aug 2, 2026 3:34pm (8d ago)| Filed | Form | Document |
|---|---|---|
| Aug 7, 2026 | 13F-HR | View |
| Aug 6, 2026 | 6-K | View |
| Aug 4, 2026 | F-N | View |
| Aug 4, 2026 | F-3ASR | View |
| Aug 3, 2026 | 4 | View |
| Aug 3, 2026 | 6-K | View |
| Jul 24, 2026 | 6-K | View |
| Jul 21, 2026 | N-PX | View |
| Jul 15, 2026 | SCHEDULE 13D/A | View |
| Jul 15, 2026 | 4 | View |
| Jul 15, 2026 | 4 | View |
| Jul 15, 2026 | 4 | View |
Filings link to the SEC’s EDGAR system. Annual/quarterly reports (10-K, 10-Q, 20-F) carry the full story; 8-K/6-K current reports are the fastest signal that something material happened.
Price Overview
Price History (1 Year)
Revenue & Net Income Trend
This company does not file structured financial statements with the U.S. SEC, so quarterly figures aren't available from our filings-based data engine. Annual figures shown here come from the sources that do cover it.
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 1.33
Total Equity: $130.58B
Shares: 11,430,860,883
Total Debt: $0.00
Cash: $566.31B
EBITDA: N/A
Total Debt: $0.00
Cash: $566.31B
Revenue: $74.36B
Revenue: $74.36B
Revenue: $74.36B
Total Equity: $130.58B
Tax Rate: 18.8%
Equity: $130.58B
Total Debt: $0.00
Cash: $566.31B
Current Liabilities: N/A
Long-Term Debt: $0.00
Total Debt: $0.00
Total Equity: $130.58B
Shares: 11,430,860,883
Shares: 11,430,860,883
CapEx: -$1.90B
Shares: 11,430,860,883
Stock Price: $22.45
Net Income: $10.84B
Industry Benchmarks
Income Statement (Annual)
Last updated: Jul 31, 2026 9:12am (11d ago)| Metric | 2024 | 2025 | 2025 | 2025 | 2026 |
|---|---|---|---|---|---|
| Revenue | $62.5B | $67.9B | $67.9B | $67.9B | $74.4B |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Expenses | $18.4B | $20.3B | $20.3B | $20.3B | $22.7B |
| Operating Income | $11.5B | $9.8B | $9.8B | $9.8B | $14.8B |
| Net Income | $8.3B | $7.9B | $7.9B | $7.9B | $10.8B |
| EBITDA | — | — | — | — | — |
| EPS | $1.04 | $1.00 | $1.00 | $1.04 | $1.34 |
| EPS (Diluted) | $1.04 | $1.00 | $1.00 | $1.03 | $1.33 |
Balance Sheet (Annual)
Last updated: Jul 31, 2026 9:12am (11d ago)| Metric | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $696.2B | $714.6B | $689.4B | $684.9B | $566.3B |
| Total Current Assets | — | — | — | — | — |
| Total Assets | $2.3T | $2.4T | $2.5T | $2.5T | $2.7T |
| Current Liabilities | — | — | — | — | — |
| Long-Term Debt | — | — | — | — | — |
| Total Liabilities | $2.2T | $2.3T | $2.4T | $2.4T | $2.5T |
| Total Equity | $102.1B | $103.2B | $115.8B | $120.6B | $130.6B |
| Retained Earnings | — | — | — | — | — |
Cash Flow (Annual)
Last updated: Jul 31, 2026 9:13am (11d ago)| Metric | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | $5.7B | $13.2B | -$9.3B | $6.4B | -$21.1B |
| Capital Expenditure | -$645.2M | -$729.2M | -$712.5M | -$825.4M | -$1.9B |
| Free Cash Flow | $5.1B | $12.5B | -$10.1B | $5.6B | -$23.0B |
| Acquisitions (net) | — | — | — | — | — |
| Net Debt Issued / (Repaid) | -$5.1B | $21.1B | -$4.9B | -$119.6B | -$1.6B |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | -$993.3M | -$2.8B | -$2.5B | -$2.6B | -$3.1B |
| Net Change in Cash | $48.8B | $18.4B | -$25.2B | -$5.1B | -$118.6B |
Growth Trends (YoY %)
Last updated: Jul 31, 2026 9:12am (11d ago)| Metric | 2025 | 2025 | 2025 | 2026 |
|---|---|---|---|---|
| Revenue Growth | +8.6% | +0.0% | +0.0% | +9.5% |
| Gross Profit Growth | — | — | — | — |
| Operating Income Growth | -15.0% | +0.0% | +0.0% | +51.1% |
| Net Income Growth | -4.6% | +0.0% | +0.0% | +36.5% |
| EBITDA Growth | — | — | — | — |
Dividend History (Last 20)
Last updated: Jul 31, 2026 9:13am (11d ago)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2025-03-31 | $0.27 | — | — | — |
| 2024-09-30 | $0.17 | — | — | — |
| 2024-03-27 | $0.13 | — | — | — |
| 2020-03-30 | $0.12 | — | — | — |
| 2007-09-26 | $0.06 | — | — | — |
| 2006-09-27 | $0.04 | — | — | — |
| 2006-03-28 | $0.03 | — | — | — |
| 2005-09-27 | $0.02 | — | — | — |
| 2005-03-28 | $0.05 | — | — | — |
| 2004-03-26 | $0.05 | — | — | — |
| 2003-03-26 | $0.03 | — | — | — |
| 2002-09-25 | $0.05 | — | — | — |
| 2002-03-26 | $0.04 | — | — | — |
Insider Trading (Recent)
Last updated: Aug 3, 2026 12:14am (8d ago)All SEC Form 4 codes
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-07-30 | MITSUBISHI UFJ FINANCIAL GROUP INC | D-Return to issuer | 414,396.00 | $213.28 | $88.4M |
| 2026-07-15 | KAMEZAWA HIRONORI | J-Other | 76,300.00 | $0.00 | $0 |
| 2026-07-15 | KAMEZAWA HIRONORI | C-Conversion | 152,700.00 | $0.00 | $0 |
| 2026-07-14 | Ochi Toshiki | J-Other | 46,800.00 | $0.00 | $0 |
| 2026-07-14 | Ochi Toshiki | C-Conversion | 93,836.00 | $0.00 | $0 |
| 2026-07-14 | Seki Hiroyuki | J-Other | 63,700.00 | $0.00 | $0 |
| 2026-07-14 | Seki Hiroyuki | C-Conversion | 127,402.00 | $0.00 | $0 |
| 2026-07-14 | Kobayashi Makoto | J-Other | 10,300.00 | $0.00 | $0 |
| 2026-07-14 | Kobayashi Makoto | C-Conversion | 20,736.00 | $0.00 | $0 |
| 2026-07-14 | KAMEZAWA HIRONORI | J-Other | 32,900.00 | $0.00 | $0 |
| 2026-07-14 | KAMEZAWA HIRONORI | C-Conversion | 65,914.00 | $0.00 | $0 |
| 2026-07-14 | Kanie Norio | J-Other | 5,400.00 | $0.00 | $0 |
| 2026-07-14 | Kanie Norio | C-Conversion | 10,826.00 | $0.00 | $0 |
| 2026-07-14 | Sakurai Takayuki | J-Other | 500.00 | $0.00 | $0 |
| 2026-07-14 | Sakurai Takayuki | C-Conversion | 1,191.00 | $0.00 | $0 |
| 2026-07-14 | Tsukiyama Keitaro | J-Other | 16,700.00 | $0.00 | $0 |
| 2026-07-14 | Tsukiyama Keitaro | C-Conversion | 33,408.00 | $0.00 | $0 |
| 2026-07-14 | Mike Kanetsugu | J-Other | 79,400.00 | $0.00 | $0 |
| 2026-07-14 | Mike Kanetsugu | C-Conversion | 158,826.00 | $0.00 | $0 |
| 2026-07-01 | Hanzawa Junichi | A-Award | 11,220.00 | $0.00 | $0 |
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
Narrative Economics
market-narrative step).
Claude Reading
The raw data here is genuinely strange and the models are papering over it. The "annual income" table shows four rows in a row at $67.90B rev / $7.94B NI (2025-03, 2025-06, 2025-09), which is clearly the same fiscal-year figure repeated — MUFG reports on a March fiscal year. So the real trajectory is FY2024 $62.5B → FY2025 $67.9B → FY2026 $74.4B revenue, and NI $8.3B → $7.9B → $10.8B. That's ~19% revenue growth over two years and ~30% NI growth, which for a Japanese megabank is genuine BoJ-normalization operating leverage, not a fluke. The 36.5% recent earnings YoY is real. ROE at 8.3% is still mediocre by global bank standards (US money-centers run 11-13%), but it's up meaningfully from the sub-6% ROEs MUFG posted through the ZIRP decade.
The synthesis verdict of $43 fair value (+89% upside) is almost certainly garbage and should be dismissed. A DCF on a bank using operating cash flow of -$21B is meaningless — banks' OCF swings wildly with loan book and deposit changes and doesn't represent distributable earnings. The "poor cash flow quality" flag and negative EV/revenue both stem from the same misapplication: standard non-financial valuation frameworks don't work on balance-sheet-driven businesses. For MUFG the right anchors are P/B (1.97x on 8.3% ROE), P/E (16.9x), and dividend yield (3.8%). At 1.97x book with an 8.3% ROE, the implied cost of equity is ~4.2% — that's rich, not cheap. Peer Japanese megabanks (SMFG, Mizuho) trade closer to 0.9-1.1x book. Either MUFG's P/B here is stale/mismeasured, or the stock is actually expensive relative to peers, not the 47% discount the narrative model claims.
The Market Forces "value trap" call and the Narrative model's "anchored, minimal intensity, durable cynicism" read are the two most honest pieces in the file, and they contradict the synthesis. I side with Market Forces directionally but not on the "correctly priced" conclusion — MUFG has actually been one of the best-performing large banks globally over the past three years precisely because the BoJ rate normalization thesis is playing out. NII expansion is real; the 16.8% earnings CAGR proves it. The contrarian argument against my own read: this is a late-cycle rate-normalization trade. BoJ policy rate is ~0.5%, terminal expectations maybe 0.75-1.0%. Most of the NIM expansion is already in the numbers. If yen strengthens materially (which typically accompanies further BoJ tightening), USD-denominated ADR holders get hit on translation even if JPY earnings hold. The insider "J-Other/C-Conversion" activity is administrative (likely trust/ESOP conversion, not directional selling) — no signal there.
My verdict: MUFG is roughly fairly valued to modestly rich here, not deeply undervalued. At $22.45, 1.97x book, 16.9x earnings, 3.8% yield — you're paying a full price for a bank whose ROE has structurally improved from 6% to 8% but is unlikely to reach 11%+ without further rate hikes that would also crimp the yen carry and loan demand. Fair value is probably $20-25, centered near current price. The 89% upside claim from the synthesis engine is a valuation-model artifact from bank OCF being negative and revenue-multiple frameworks misfiring — ignore it. The value-trap framing from Market Forces is directionally right on the structural headwinds (demographics, deflation risk if BoJ overshoots, CRE exposure in US via MUFG's Union Bank legacy and current MUAH holdings) but wrong that the market has already fully priced this — the recent price action and earnings momentum suggest the market is still catching up to normalization. For a US-based dividend investor, 3.8% yield + low-single-digit organic growth is a reasonable but not exciting proposition. I dissent from the synthesis "undervalued at $43" and lean fair-value with a slight bearish tilt versus consensus that thinks Japan bank re-rating has legs.
GPT Reading
At $22.45, MUFG does not read to me like a 2x-book, high-teens P/E bank that deserves a scarcity premium; it reads like a good franchise whose recent earnings uplift is being overcapitalized. The core fact pattern is solid but not spectacular: revenue rose from $62.50B in 2024 to $67.90B in 2025 and $74.36B in 2026, while net income moved from $8.32B to $7.94B to $10.84B. That last year is clearly the best in the set, but the profitability it implies is still only 8.3% ROE on $130.58B of equity and 0.41% ROA. For a globally systemic bank, 8.3% ROE is improvement, not evidence of a structurally transformed earnings engine. Paying 1.97x book for an 8%-ish ROE bank is hard to justify unless you think returns are about to move materially higher and stay there. The current multiple implies something closer to durable low-teens returns than the data actually show.
What stands out most is the tension between the valuation models calling the stock dramatically undervalued and the accounting/economic quality of the reported performance. The “cheapness” argument is built on earnings and book value, but the latest annual cash flow shows operating cash flow of negative $21.09B and free cash flow of negative $22.99B. For banks, conventional FCF is a noisy and often misleading metric because balance-sheet flows swamp industrial-style cash conversion, so I would not treat negative FCF as dispositive. But I also would not ignore it while simultaneously taking a DCF that spits out nearly 90% upside at face value. Add in a reported negative EV/revenue anomaly and duplicate annual rows in the income table, and the right conclusion is not “the stock is obviously half price”; it is “be very careful about model outputs here.” When the primary valuation case depends on noisy inputs and the actual headline profitability is only moderate, I fade the heroic upside math.
The business is plainly improving. Operating income reached $14.82B in 2026 versus $11.55B in 2024, and operating margin improved to 19.9%. Net income jumping 36.5% year over year is real progress, and a 3.8% dividend yield gives investors paid patience. But that is exactly why I think the market already understands the story. A $253B market cap against $10.84B of net income is a full price for a bank still earning less than 10% on equity. If I crudely anchor on what would be more normal for a mature diversified bank with this return profile, something like 1.2x-1.5x book or roughly 10x-13x earnings feels more defendable than 1.97x and 16.9x. On $130.58B of equity, 1.3x-1.5x book would imply equity value around $170B-$196B, materially below today’s $253B. That points to a share price more in the mid-to-high teens than the low twenties.
The strongest case against my read is that I may be underestimating how much earnings power is still to come if Japanese rate normalization continues. If 2026’s $10.84B net income is not a peak but an early step, today’s 16.9x trailing P/E can compress quickly. A move from 8.3% ROE toward 11%-13% ROE would make 2x book much less offensive, especially for a fortress-scale institution with $566.31B of cash and a sticky domestic franchise. The revenue trend is also better than the usual Japan-bank stereotype: 4.7% CAGR over the period and 9.5% recent growth are healthy for a mature megabank. A bull would also rightly argue that Western investors have chronically undervalued Japanese financials for decades, so what looks optically rich versus book may simply reflect a regime change in rates and capital returns. I weigh that evidence less heavily because the reported numbers do not yet show that regime change flowing through to truly high-quality double-digit returns on equity.
What would change my mind is simple: if MUFG can put up another 12-18 months showing net income sustained above roughly $11.5B-$12.5B while lifting ROE to at least 10%-11% without a deterioration in capital, then the current price becomes much easier to defend and even modestly attractive. I would also want to see cleaner evidence that the earnings uplift is not just accounting noise or one-time balance-sheet benefit masked by bank cash-flow complexity. Conversely, if earnings slip back toward the 2024-2025 range of about $8B while book-value multiple stays near 2x, the stock is plainly over-earning in the market’s imagination. Right now, I think investors are paying for the normalized future before MUFG has fully earned it in the numbers.
Grok Reading
MUFG at $22.45 is a bank that has already been paid for the Japan re-rating story. Fiscal 2026 revenue of $74.36B and net income of $10.84B mark a clear step-up from the prior run-rate near $68B and $7.9B, delivering a 9.5% revenue lift and 36.5% earnings jump with operating and net margins of 19.9% and 14.6%. That is real improvement, not accounting noise, and the 16.8% earnings CAGR confirms the multi-year turn higher as BoJ policy leaves the zero bound. Yet ROE is still only 8.3% and ROA a wafer-thin 0.41%. At 1.97x book and 16.9x trailing earnings, the market is already capitalizing a mid-teens ROE that has not arrived. A diversified megabank earning high-single-digit returns on equity does not deserve nearly 2x tangible capital unless rate normalization and fee income push sustainable ROE toward 12%; until that is demonstrated, the multiple is full. The $566B cash pile and fortress deposit franchise are genuine, but they are already inside the $253B market cap. Negative operating cash flow of –$21B and FCF of –$23B look alarming on a corporate template, though for a balance-sheet lender they largely reflect loan growth rather than earnings fiction; still, they strip away any claim that this is a cash-compounding machine at a bargain.
The valuation synthesis calling for $42–43 (nearly 4x book) is disconnected from bank economics and should be ignored. Equally, the pure value-trap read underweights the fact that earnings power has already moved from roughly $8B to nearly $11B and that a 3.83% dividend yield supplies a tangible income floor while the market waits for further NIM expansion. Structural Japan headwinds—demographics, still-low absolute rates, regulatory drag—are real and durable, which is why foreign investors have kept a multi-decade discount on the sector; they do not, however, erase the cyclical earnings recovery now visible in the numbers.
The strongest opposing case is straightforward: if BoJ normalization continues and MUFG converts its rate-sensitive book into a sustained 11–12% ROE, today’s 1.97x P/B becomes ordinary rather than rich, the 16.9x P/E compresses via earnings growth rather than multiple contraction, and the stock can grind higher while paying nearly 4%. Recent 36% earnings growth and the 4.7% revenue CAGR give that path empirical support, and Japanese governance reforms plus buybacks could tighten the equity base. I weigh this less heavily because the re-rating from sub-1x book to almost 2x has already discounted a large fraction of that optimism; further upside requires execution, not just narrative.
I would flip to outright undervalued if the next two semi-annual prints show ROE sustainably above 10% with stable credit costs and net interest income still rising, or if the shares retreated toward 1.3–1.4x book while earnings held. I would flip bearish if NI fell back below $9B, if credit costs spiked on CRE or China exposure, or if BoJ stalled and the P/E remained above 15x on flattening earnings.
Big-3 Panel — where each AI stands
Advanced Analysis Forensic deep-dive · four lenses
MUFG is a mature, diversified megabank reporting revenue growth from $62.5B (2024) to $74.4B (2026) with operating margin expanding to 19.9% and net income of $10.8B. For a bank the size of the balance sheet dwarfs the income statement, and standard non-financial forensic tools misfire here: the Altman Z of 0.11 flags 'distress' but Z-scores are not meaningful for banks (all banks look distressed on Z because leverage is the business model), and OCF/NI of 0.01x with negative FCF reflects loan-book growth and trading-asset movements, not earnings manipulation. Liquid 'cash' of $566B is largely regulatory/operational bank liquidity, not shareholder free capital. The 'diluted share CAGR of 250%' is almost certainly a data artifact from an ADR ratio change (share count jumps from 75.6M to ~11.5B in one step, then declines gradually from 11.68B to 11.43B) - the underlying share count is actually shrinking modestly, consistent with MUFG's known buyback programs. Insider tape shows only C-Conversion and J-Other codes (no open-market P/S), which is normal for Japanese executive compensation mechanics and non-directional. Net: a scaled, profitable, systemically important bank with improving margins and modestly declining share count. Bank-specific risks (credit cycle, JGB duration, cross-shareholdings) are not visible in this data and require filing-level work.
Verify before trusting this (6)
- Actual share count history in native Japanese shares (not ADRs) to confirm buyback discipline vs. dilution
- CET1 ratio, NPL ratio, and credit cost trend from the annual securities report
- Net interest margin trajectory and sensitivity to BoJ rate normalization
- Size and mark of cross-shareholdings and unrealized gains/losses on securities portfolio
- Nature of the J-Other/C-Conversion insider entries (likely stock-based comp vesting mechanics under Japanese rules)
- Whether the 2024 vs 2025 share count jump is an ADR ratio change or a genuine equity issuance
The e2e composite pins fair value at $43.28 (signal-adjusted $42.54) with 89% upside, anchored between an EPV floor of $59.97 and an anchored-PE of $26.58. I trust the EPV floor least here (banks + Japan means EPV can overstate durable earnings power given low ROEs and cross-shareholding gains), so I lean on the anchored-PE $26.58 as the more defensible marker. Even that conservative anchor implies roughly 18% upside from $22.45, and the truth likely sits between the two anchors given a solid-quality franchise and a ~4% yield backing the wait.
Verify before trusting this (5)
- Latest NIM trajectory and sensitivity to BoJ rate normalization
- Credit quality trends and NPL ratios in domestic and overseas books
- Cross-shareholding unwind pace and mark-to-market gains vs core earnings
- Buyback cadence and total shareholder yield vs prior guidance
- Duration risk and unrealized losses on securities portfolio
MUFG sits in the calmest possible sentiment bucket: post-bubble-cynicism with minimal intensity, low cult coefficient, and a durable but sleepy story. There is no mania to unwind and no collapse in progress - the 47% discount is a structural fact the market has priced for years, not a fresh narrative break. With beta of 0.31, the mildly-positive-but-fragile global tape (VIX 16, S&P off 1.6%, neutral +22) barely registers here; a risk-off flinch that would gut a story stock leaves MUFG almost untouched.
Verify before trusting this (4)
- BOJ rate-path signals - any dovish surprise would sap the one active tailwind for Japanese banks
- Foreign-flow data into TOPIX banks - a rotation would move MUFG more than earnings will
- Any crack in the yen or Japanese-bank credit story that would flip the sleepy narrative to active headwind
- US regional/global bank sentiment - contagion channel even at low beta
This lens hasn't been run for this ticker yet.